These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17652183)

  • 1. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8.
    Haskell CA; Horuk R; Liang M; Rosser M; Dunning L; Islam I; Kremer L; Gutiérrez J; Marquez G; Martinez-A C; Biscone MJ; Doms RW; Ribeiro S
    Mol Pharmacol; 2006 Jan; 69(1):309-16. PubMed ID: 16221874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
    Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
    J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R; Callahan N; Xu Z; Wu N; Thibonnier M; Shoham M
    J Pharmacol Exp Ther; 2006 Feb; 316(2):564-71. PubMed ID: 16234409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC; Rosenkilde MM
    Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8.
    Lüttichau HR; Gerstoft J; Schwartz TW
    J Leukoc Biol; 2001 Aug; 70(2):277-82. PubMed ID: 11493620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3.
    Rosenkilde MM; Kledal TN; Schwartz TW
    Mol Pharmacol; 2005 Jul; 68(1):11-9. PubMed ID: 15788740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).
    Ott TR; Lio FM; Olshefski D; Liu XJ; Struthers RS; Ling N
    Biochemistry; 2004 Mar; 43(12):3670-8. PubMed ID: 15035637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
    Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8.
    Jiang S; Lin X; Wu L; Wang L; Wu Y; Xu Z; Xu F
    Sci Adv; 2024 Feb; 10(5):eadj7500. PubMed ID: 38306437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of RNA aptamers that block CCL1 chemokine function.
    Marro ML; Daniels DA; Andrew DP; Chapman TD; Gearing KL
    Biochem Biophys Res Commun; 2006 Oct; 349(1):270-6. PubMed ID: 16930539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
    Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
    Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.
    Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR
    Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
    Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
    J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.
    Luz JG; Yu M; Su Y; Wu Z; Zhou Z; Sun R; Wilson IA
    J Mol Biol; 2005 Oct; 352(5):1019-28. PubMed ID: 16140327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
    Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
    Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.
    Connolly S; Skrinjar M; Rosendahl A
    Biochem Pharmacol; 2012 Mar; 83(6):778-87. PubMed ID: 22209712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.